Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark J. Rosenblum currently holds 11,363 shares of Salarius Pharmaceuticals, Inc. (SLRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark J. Rosenblum has been a net buyer of SLRX stock. They have purchased $110.0K and sold $0 worth of shares.
Mark J. Rosenblum's most recent insider trade was on Aug 31, 2026, when they sold 9,682 shares at $0.00 per share.
Mark J. Rosenblum serves as Executive at Salarius Pharmaceuticals, Inc. (SLRX). They have executed 27 insider transactions totaling $110.0K over their tenure at the company.
Mark J. Rosenblum holds the position of Executive at Salarius Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Mark J. Rosenblum has shown a buying trading pattern, with $110.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Mark J. Rosenblum was on Oct 24, 2013, when they purchased $48.0K worth of ADXS shares. This transaction involved 12,000 shares at $4.00 per share.
Mark J. Rosenblum currently owns 11,363 shares of Salarius Pharmaceuticals, Inc. (SLRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark J. Rosenblum's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark J. Rosenblum has 27 Form 4 filings on record as an insider at Salarius Pharmaceuticals, Inc..
Set alerts for Mark J. Rosenblum and 40,000+ other insiders.